Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix to Co-Market Strand Genomics Microarray Analysis Software

NEW YORK, July 9 (GenomeWeb News) - Acacia's CombiMatrix group will market Strand Genomics' microarray analysis software, the companies said yesterday.

 

Under the agreement, Newport Beach, Calif.-based CombiMatrix will co-market Strand's Avadis software, a data analysis tool for microarray gene expression.

 

The companies will also co-develop an interface that will facilitate ordering CombiMatrix CustomArray products through Avadis. Strand Genomics is located in Bangalore, India.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.